Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemokine CXCL13 as a Marker of Disease Activity in Systemic Lupus Erythematosus

NCT03752983 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03752983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03752983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemokine CXCL13 as a Marker of Disease Activity in Systemic Lupus Erythematosus
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
December 1, 2020
Enrollment
86 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus